Bronchodilator response in adults with bronchiectasis: correlation with clinical parameters and prognostic...

Area of Science:

• Pulmonary Medicine
• Respiratory Research
• Clinical Trials

Background:

• Bronchial dilation testing assesses airway reversibility in adults with bronchiectasis.
• Bronchodilator response (BDR) utility in predicting lung function decline and exacerbation risks is under investigation.

Purpose of the Study:

• To investigate the association between bronchodilator response (BDR) and clinical parameters in bronchiectasis.
• To determine the utility of BDR in indicating lung function decline and risks of bronchiectasis exacerbations (BEs).

Main Methods:

• 129 clinically stable bronchiectasis patients were recruited.
• Baseline assessments included sputum analysis, spirometry, bronchial dilation test, and HRCT.
• Patients were followed for 1 year to assess BEs and lung function trajectories.

Main Results:

• Significant BDR correlated negatively with baseline FEV1 but not inflammatory markers.
• Significant BDR was associated with poorer spirometry but not accelerated lung function decline.
• A trend towards lower risk of first BEs was observed in patients with significant BDR.

Conclusions:

• Significant BDR is associated with poorer baseline lung function in bronchiectasis patients.
• The predictive value of BDR for future bronchiectasis exacerbations requires validation in larger cohorts.